Harneet Arora completed her Bachelors in Physiotherapy from India and is currently pursuing a PhD in Rehabilitation Science under the mentorship of Dr. Krista Vandenborne. Harneet’s research interest focus on examining the natural history of disease progression in both upper and lower extremities in boys with Duchenne muscular dystrophy using functional and MR measures.
Alison Barnard received her Bachelors of Science in Earth, Atmospheric, and Planetary Science from the Massachusetts Institute of Technology and her Doctorate of Physical Therapy from the University of Alabama at Birmingham. She is currently pursuing a PhD in Rehabilitation Science under the mentorship of Drs. Krista Vandenborne and Glenn Walter. Her research interests include using magnetic resonance imaging and spectroscopy techniques to assess muscle health in Duchenne muscular dystrophy. Specifically, she is using MRI methods to investigate the effects of failed muscle regeneration on respiratory function in DMD.
Abhinandan Batra received his Bachelors in Physiotherapy from Guru Nanak Dev University, India, and his Masters from Georgia State University, Atlanta. Abhinandan received his PhD in Rehabilitation Sciences at the University of Florida under the direction of his mentor Dr. Krista Vandenborne in 2017. Dr. Batra continues to work as a Post-Doctoral Fellow with Drs. Krista Vandenborne, Glenn Walter, Sean Forbes focusing on non-Invasive monitoring of Cardiac and skeletal muscle involvement in muscular dystrophies.
- George Vasilakos received his Bachelors in Biology from York University in Toronto, and his Masters in Applied Physiology from Coventry University in Coventry, UK. George received his PhD in Molecular Physiology from National and Kapodistrian University of Athens Medical School. He currently works in the Molecular Physiology of Muscle Laboratory under Elisabeth Barton. George’s research interests include the role of muscle insulin-like growth factor I in regulation of glucose homeostasis, the use of insulin-like growth factor I to promote muscle growth and repair, and muscle load sensing through sarcoglycan complex.
Zachary received his Bachelor of Science in Biology from Indiana University. He is currently a graduate student in H. Lee Sweeney’s lab. Zachary is interested in genetic modifiers of Duchenne Muscular Dystrophy pathology, and developing novel therapeutics for treating the disease.
David Hammers received his PhD in Exercise Physiology at the University of Texas at Austin. Dr. Hammers research interests focus on muscle diseases and skeletal muscle regeneration. David was a Post-Doctoral Fellow in the Dr. Lee Sweeney lab with a focus on Duchenne Muscular Dystrophy and muscle fibrosis, and is currently a Research Assistant Professor in the Department of Pharmacology and Therapeutic at the University of Florida.
Ravneet Vhora received his PhD in Rehabilitation Science and is interested in studying morphological and functional skeletal muscle changes in various dystrophies, cachexia and aging. He worked in the muscle physiology lab under Glenn A Walter. Currently, he is working on monitoring disease progression in a mouse model of pancreatic ductal adenocarcinoma (PDA). He is also working on effects of Pulsed High intensity focused ultrasound (pHIFU) in subcutaneous, orthotopic and KPC mice and monitoring these effects using multi-parametric MRI (14T). In addition, he is working on characterizing two different preclinical mouse models of Duchenne muscular dystrophy i.e. mdx4cv and mdx/dba using high field MRI (14T). Ravneet has moved to the Radiology Department at the University of Washington.
Yun Yang received his Medical Degree in 2010 from Luzhou Medical College in Sichuan China. Dr. Yang worked as a Research Scholar/Post-Doctoral Associate in the H. Lee Sweeney Laboratory for 2 years focused on evaluating potential therapeutic agents for Duchenne Muscular Dystrophy (DMD). Specifically, Dr. Yang performed studies to evaluate the impact on dystrophin-deficient mouse muscles treated with compounds or combination of compounds, including prednisolone, tamoxifen, a TGF-beta1 inhibitory antibody, and a myostatin inhibitor. Dr. Yang also followed up on a report of a gastrointestinal phenotype in SMN deficient patients by investigating the SMN (survival motor neuron protein)- deficient mouse model. Yun will be returning to China where he will be employed as a surgeon attending in West China Hospital, Chengdu Shangjinnanfu, and specializes in colorectal cancer and pelvic floor dysfunction in clinic and also conduct basic research on GI smooth muscle pathology.